Eating disorder experts are warning the telehealth prescribing of GLP-1 weight-loss treatments, is putting vulnerable lives at risk. They're calling for tighter advertising rules and mandated face-to-face monitoring, with one company accused of pushing the boundaries in its marketing of the product.
